About EDAP TMS SA
EDAP TMS SA (NASDAQ:EDAP) specializes in developing, manufacturing, and marketing advanced medical equipment for urological disorders, primarily focusing on minimally invasive therapies for the treatment of prostate cancer, urinary tract stones, and other significant health conditions. Its flagship technologies include Ablatherm for High Intensity Focused Ultrasound (HIFU) therapy and Focal One for the precise ablation of prostate tissue, alongside the Sonolith i-move, a leading device in extracorporeal shock wave lithotripsy (ESWL). With a strong commitment to innovation and the improvement of patient outcomes, EDAP continuously works on the enhancement of its current product lineup and the development of new technologies aimed at advancing urological care across the globe.
Snapshot
Operations
Products and/or services of EDAP TMS SA
- Focal One - Advanced HIFU technology for the precise targeting and treatment of localized prostate cancer.
- Ablatherm HIFU - Offers a minimally invasive treatment option for prostate cancer using high-intensity focused ultrasound.
- ExactVu - High-resolution micro-ultrasound system for prostate imaging and biopsy guidance.
- Sonolith i-move - An integrated lithotripter system designed for treating kidney stones with extracorporeal shock wave therapy.
- EDAP TMS Cloud - A cloud-based data management solution for storing, managing, and analyzing treatment data.
EDAP TMS SA executive team
- Mr. Ryan RhodesCEO & Director
- Mr. Ken MobeckChief Financial Officer
- Mr. Carre EmmanuelChief Operating Officer
- Mr. Francois DietschChief Accounting Officer
- Ms. Blandine ConfortHead of Legal Affairs & Investor Relations and Secretary
- Mr. Frederic PechPresident of EDAP TMS France
- Mr. Jean-Francois BachelardPresident & Chief Executive Officer of Edaptechnomed Co. Ltd.